Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the clinical efficacy and safety of eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria, and to evaluate which patients might benefit most from its use.